Table of Contents

1 Study Coverage

• 1.1 Myoview Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Myoview Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 5 ml
  • 1.2.3 30 ml
• 1.3 Market by Application
  • 1.3.1 Global Myoview Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospital
  • 1.3.3 Clinic
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Myoview Sales Estimates and Forecasts 2017-2028
• 2.2 Global Myoview Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Myoview Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Myoview Sales by Region
  • 2.4.1 Global Myoview Sales by Region (2017-2022)
  • 2.4.2 Global Sales Myoview by Region (2023-2028)
• 2.5 Global Myoview Revenue by Region
  • 2.5.1 Global Myoview Revenue by Region (2017-2022)
  • 2.5.2 Global Myoview Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Myoview Sales by Manufacturers
  • 3.1.1 Global Top Myoview Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Myoview Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Myoview in 2021
• 3.2 Global Myoview Revenue by Manufacturers
  • 3.2.1 Global Myoview Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Myoview Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Myoview Revenue in 2021
• 3.3 Global Myoview Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Myoview Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Myoview Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Myoview Sales by Type
  • 4.1.1 Global Myoview Historical Sales by Type (2017-2022)
  • 4.1.2 Global Myoview Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Myoview Sales Market Share by Type (2017-2028)
• 4.2 Global Myoview Revenue by Type
  • 4.2.1 Global Myoview Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Myoview Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Myoview Revenue Market Share by Type (2017-2028)
• 4.3 Global Myoview Price by Type
  • 4.3.1 Global Myoview Price by Type (2017-2022)
  • 4.3.2 Global Myoview Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Myoview Sales by Application
  • 5.1.1 Global Myoview Historical Sales by Application (2017-2022)
  • 5.1.2 Global Myoview Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Myoview Sales Market Share by Application (2017-2028)
• 5.2 Global Myoview Revenue by Application
  • 5.2.1 Global Myoview Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Myoview Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Myoview Revenue Market Share by Application (2017-2028)
• 5.3 Global Myoview Price by Application
  • 5.3.1 Global Myoview Price by Application (2017-2022)
  • 5.3.2 Global Myoview Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Myoview Market Size by Type
  • 6.1.1 North America Myoview Sales by Type (2017-2028)
  • 6.1.2 North America Myoview Revenue by Type (2017-2028)
• 6.2 North America Myoview Market Size by Application
  • 6.2.1 North America Myoview Sales by Application (2017-2028)
  • 6.2.2 North America Myoview Revenue by Application (2017-2028)
• 6.3 North America Myoview Market Size by Country
  • 6.3.1 North America Myoview Sales by Country (2017-2028)
  • 6.3.2 North America Myoview Revenue by Country (2017-2028)
  • 6.3.3 United States
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Myoview Market Size by Type
  • 7.1.1 Europe Myoview Sales by Type (2017-2028)
  • 7.1.2 Europe Myoview Revenue by Type (2017-2028)
• 7.2 Europe Myoview Market Size by Application
  • 7.2.1 Europe Myoview Sales by Application (2017-2028)
  • 7.2.2 Europe Myoview Revenue by Application (2017-2028)
• 7.3 Europe Myoview Market Size by Country
  • 7.3.1 Europe Myoview Sales by Country (2017-2028)
  • 7.3.2 Europe Myoview Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Myoview Market Size by Type
  • 8.1.1 Asia Pacific Myoview Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Myoview Revenue by Type (2017-2028)
• 8.2 Asia Pacific Myoview Market Size by Application
  • 8.2.1 Asia Pacific Myoview Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Myoview Revenue by Application (2017-2028)
• 8.3 Asia Pacific Myoview Market Size by Region
  • 8.3.1 Asia Pacific Myoview Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Myoview Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 China Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia

9 Latin America

• 9.1 Latin America Myoview Market Size by Type
  • 9.1.1 Latin America Myoview Sales by Type (2017-2028)
  • 9.1.2 Latin America Myoview Revenue by Type (2017-2028)
• 9.2 Latin America Myoview Market Size by Application
  • 9.2.1 Latin America Myoview Sales by Application (2017-2028)
  • 9.2.2 Latin America Myoview Revenue by Application (2017-2028)
• 9.3 Latin America Myoview Market Size by Country
  • 9.3.1 Latin America Myoview Sales by Country (2017-2028)
  • 9.3.2 Latin America Myoview Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Myoview Market Size by Type
  • 10.1.1 Middle East and Africa Myoview Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Myoview Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Myoview Market Size by Application
  • 10.2.1 Middle East and Africa Myoview Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Myoview Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Myoview Market Size by Country
  • 10.3.1 Middle East and Africa Myoview Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Myoview Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 GE Healthcare
  • 11.1.1 GE Healthcare Corporation Information
  • 11.1.2 GE Healthcare Overview
  • 11.1.3 GE Healthcare Myoview Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 GE Healthcare Myoview Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 GE Healthcare Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Myoview Industry Chain Analysis
• 12.2 Myoview Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Myoview Production Mode & Process
• 12.4 Myoview Sales and Marketing
  • 12.4.1 Myoview Sales Channels
  • 12.4.2 Myoview Distributors
• 12.5 Myoview Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Myoview Industry Trends
• 13.2 Myoview Market Drivers
• 13.3 Myoview Market Challenges
• 13.4 Myoview Market Restraints

14 Key Findings in The Global Myoview Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details

Summary:

Market Analysis and Insights: Global Myoview Market
Myoview™ 30 mL (Kit for the Preparation of Technetium Tc-99m Tetrofosmin for Injection) is indicated for myocardial perfusion imaging under rest and/or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease.
Due to the COVID-19 pandemic, the global Myoview market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 5 ml accounting for % of the Myoview global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Myoview market size is valued at US$ million in 2021, while the US and Europe Myoview are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Myoview landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Myoview include GE Healthcare. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
5 ml
30 ml
Segment by Application
Hospital
Clinic
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Myoview market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
GE Healthcare
Frequently Asked Questions
Which is the most lucrative product segment in the Myoview market?
Which are the prominent strategies of the Myoview market players?
Which factors are increasing the competition in the Myoview market?
Which are the recommendations provided by the Myoview industry experts?
Which region will witness rewarding growth during the forecast period?
What factors will curb the Myoview market growth?
Which product segment will register the fastest growth rate in the Myoview market?
Which emerging trends will impact the Myoview market growth?
Which are the high-impact rendering factors in the Myoview market?
Which companies will maintain their lead on the Myoview market?